Home
Scholarly Works
Design and baseline characteristics of the DREAM...
Conference

Design and baseline characteristics of the DREAM (diabetes REduction assessment with ramipril and rosiglitazone medication) trial

Authors

Gerstein HC; Yusuf S; Holman RR; Bosch J

Volume

53

Pagination

pp. A483-A483

Publisher

AMER DIABETES ASSOC

Publication Date

June 1, 2004

Name of conference

64th Annual Meeting of the American-Diabetes-Association

Conference place

Orlando, FL

Conference start date

June 4, 2004

Conference end date

June 8, 2004

Conference proceedings

DIABETES

ISSN

0012-1797

Labels

Fields of Research (FoR)

Contact the Experts team